Filing Details
- Accession Number:
- 0001209191-10-030463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-26 13:00:00
- Reporting Period:
- 2010-05-25
- Filing Date:
- 2010-05-26
- Accepted Time:
- 2010-05-26 11:59:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408593 | Leo Pavliv | 2525 West End Ave. Suite 950 Nashville TN 37203 | Sr. Vice President, Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-25 | 5,000 | $6.78 | 20,145 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.77 to $6.779. The reporting person undertakes to provide to Cumberland Pharmaceuticals, any security holder of Cumberland Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."
Billionaire Hedge Funds
